Working… Menu

Convection-Enhanced Delivery (CED) of MDNA55 in Adults With Recurrent or Progressive Glioblastoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02858895
Recruitment Status : Completed
First Posted : August 8, 2016
Last Update Posted : January 15, 2021
Information provided by (Responsible Party):
Medicenna Therapeutics, Inc.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : September 12, 2019
Actual Study Completion Date : October 31, 2019
Certification/Extension First Submitted : January 13, 2021